| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 5'-phosphomonoesters | 1.68e-04 | 37 | 58 | 3 | GO:0016891 | |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 3.23e-04 | 46 | 58 | 3 | GO:0016893 | |
| Domain | Znf_C3HC4_RING-type | 1.88e-03 | 172 | 57 | 4 | IPR018957 | |
| Domain | zf-C3HC4 | 4.77e-03 | 223 | 57 | 4 | PF00097 | |
| Pubmed | 1.64e-05 | 29 | 59 | 3 | 21829377 | ||
| Pubmed | Regulation of ETAA1-mediated ATR activation couples DNA replication fidelity and genome stability. | 5.65e-05 | 122 | 59 | 4 | 31615875 | |
| Pubmed | 1.01e-04 | 9 | 59 | 2 | 19448621 | ||
| Pubmed | 3.79e-04 | 17 | 59 | 2 | 7557990 | ||
| Pubmed | 4.75e-04 | 19 | 59 | 2 | 22267201 | ||
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 5.72e-04 | 608 | 59 | 6 | 36089195 | |
| Pubmed | 7.07e-04 | 102 | 59 | 3 | 10231032 | ||
| Pubmed | UIMC1 NUDT12 PHYKPL ZNF136 CCNDBP1 SELENBP1 TEX264 TBC1D7 PTPN23 | 8.11e-04 | 1477 | 59 | 9 | 31515488 | |
| Pubmed | Whole-genome sequencing reveals host factors underlying critical COVID-19. | 8.28e-04 | 25 | 59 | 2 | 35255492 | |
| Pubmed | 8.83e-04 | 251 | 59 | 4 | 28077445 | ||
| Pubmed | Genetics of rheumatoid arthritis contributes to biology and drug discovery. | 9.27e-04 | 112 | 59 | 3 | 24390342 | |
| Pubmed | Regulation of meiotic telomere dynamics through membrane fluidity promoted by AdipoR2-ELOVL2. | 1.12e-03 | 29 | 59 | 2 | 38485951 | |
| Pubmed | 1.44e-03 | 33 | 59 | 2 | 23583979 | ||
| Pubmed | 1.47e-03 | 1293 | 59 | 8 | 15342556 | ||
| Interaction | ANKH interactions | 1.27e-05 | 17 | 55 | 3 | int:ANKH | |
| Interaction | CLSTN2 interactions | 2.86e-05 | 22 | 55 | 3 | int:CLSTN2 | |
| Cytoband | 15q14-q15 | 1.62e-05 | 5 | 59 | 2 | 15q14-q15 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p13 | 5.54e-04 | 797 | 59 | 6 | chr19p13 | |
| Cytoband | 19p13.3 | 3.57e-03 | 237 | 59 | 3 | 19p13.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr6p24 | 3.71e-03 | 70 | 59 | 2 | chr6p24 | |
| GeneFamily | Beta 3-glycosyltransferases | 1.15e-03 | 24 | 38 | 2 | 426 | |
| GeneFamily | Ring finger proteins | 2.57e-03 | 275 | 38 | 4 | 58 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.44e-06 | 191 | 59 | 5 | 6e1d00404d795ec7cf60f685e42e4ad9a16ac596 | |
| ToppCell | Control-Epithelial-Ciliated_cells|Control / Condition, Lineage and Cell class | 5.44e-06 | 191 | 59 | 5 | ea1d2c6838119b7019e9a2ff71d6212262b51b57 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.44e-06 | 191 | 59 | 5 | f158e393976b685b896a41871bda1ab65a8b58f5 | |
| ToppCell | Control-Epithelial|Control / Condition, Lineage and Cell class | 5.44e-06 | 191 | 59 | 5 | 6228302febdb3dffe37dece7062d27ac9ccc6d4b | |
| ToppCell | Control-Neu_4|World / 5 Neutrophil clusters in COVID-19 patients | 1.03e-04 | 184 | 59 | 4 | ce7f044956613118ee2e9fb6af2455c3166cb414 | |
| ToppCell | normal-na-Lymphocytic_NK-NK_dim-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.06e-04 | 185 | 59 | 4 | b1a8a8c4d0fc7605eabc17dcb6bd9e8ab4fd578c | |
| ToppCell | BAL-Control-Epithelial-Epithelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.19e-04 | 191 | 59 | 4 | df8a1a6e78aa0cb941b94cb676bd6891d79f3687 | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.19e-04 | 191 | 59 | 4 | 7b5da29109aa28768c67653a1bc0f385c2d2269b | |
| ToppCell | Healthy_Control-Epithelial-Epithelial|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 1.19e-04 | 191 | 59 | 4 | 15b9386b26caaa7d15f704c4a18881e1ce918a21 | |
| ToppCell | BAL-Control-Epithelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.19e-04 | 191 | 59 | 4 | 9f19098f260d5542aa8ba7eb6f91b44d0db6e0a4 | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.19e-04 | 191 | 59 | 4 | fa9f8b50bfc7911c858bc2f9dcd204873d97ac61 | |
| ToppCell | Control-Epithelial|Control / Disease group,lineage and cell class (2021.01.30) | 1.19e-04 | 191 | 59 | 4 | b78547dae8328244a47c83346447bdd787efbcae | |
| ToppCell | Healthy_Control-Epithelial-Epithelial-|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 1.19e-04 | 191 | 59 | 4 | 28caedb2e448e0c7f494100d714fa7cdcf150691 | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.19e-04 | 191 | 59 | 4 | b4e335e798c9617356b8e24412f9270c42dce656 | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.19e-04 | 191 | 59 | 4 | c4b223b33c020a064f576711a3d700eb60a2d737 | |
| ToppCell | Healthy_Control-Epithelial|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 1.19e-04 | 191 | 59 | 4 | fdcdadbfc9ccae175abe4de8c7428ac4f6a67fde | |
| ToppCell | BAL-Control-Epithelial-Epithelial|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.19e-04 | 191 | 59 | 4 | c50d6a1a6209ed4157f7c00fc24d4ecb43790f44 | |
| ToppCell | BAL-Control-Epithelial|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.19e-04 | 191 | 59 | 4 | 5129f778a9283bfac4ff322c21c5ca71da4b7174 | |
| ToppCell | Control-Epithelial-Ciliated|Control / Disease group,lineage and cell class (2021.01.30) | 1.19e-04 | 191 | 59 | 4 | cdc08e95a0c8f5c7a8d01b6bbaafdb54ef2f0d12 | |
| ToppCell | severe-dn_T|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.37e-04 | 198 | 59 | 4 | d4f2213af45ada47e6c62675f468ce05692db507 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.40e-04 | 199 | 59 | 4 | 1ee4010d8557564e25e8ee00b914c2dfd9037838 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.40e-04 | 199 | 59 | 4 | 1df69c0cb5f759f6a2152521842506a75bb95cae | |
| ToppCell | Mild-Epithelial|Mild / Condition, Lineage, Cell class and cell subclass | 1.40e-04 | 199 | 59 | 4 | ec5fff80e2a8a94fbaf1fdcc6d45c8d7c6252e18 | |
| ToppCell | Mild-Epithelial-Epithelial-|Mild / Condition, Lineage, Cell class and cell subclass | 1.40e-04 | 199 | 59 | 4 | 81115bbd2c10bfdd38376d2075f03a59c31870d2 | |
| ToppCell | Mild-Epithelial-Epithelial|Mild / Condition, Lineage, Cell class and cell subclass | 1.40e-04 | 199 | 59 | 4 | 91308b255783ad4029e5575028c18d7550832c51 | |
| ToppCell | BAL-Mild-Epithelial|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.40e-04 | 199 | 59 | 4 | 74087b4b5e567310fc4ac58fb267ff651a180680 | |
| ToppCell | Mild_COVID-19-Epithelial|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 1.40e-04 | 199 | 59 | 4 | 72689bda7476930887ae007682fcab27f956f050 | |
| ToppCell | BAL-Mild-Epithelial|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.40e-04 | 199 | 59 | 4 | 00b5ce099c50a5e1786ce2b3a06ee0931a8205a4 | |
| ToppCell | Control-Control-Myeloid-immature_Neutrophil|Control / Disease, condition lineage and cell class | 1.42e-04 | 200 | 59 | 4 | 118321ac443feb42aee171baccfc4610f00a8822 | |
| Disease | phosphatidate measurement | 3.66e-04 | 15 | 56 | 2 | EFO_0020047 | |
| Disease | alpha-linolenic acid measurement | 1.03e-03 | 25 | 56 | 2 | EFO_0007759 | |
| Disease | docosapentaenoic acid measurement | 1.20e-03 | 27 | 56 | 2 | EFO_0006809 | |
| Disease | abdominal:gluteofemoral adipose tissue ratio measurement | 1.39e-03 | 29 | 56 | 2 | EFO_0803320 | |
| Disease | eicosapentaenoic acid measurement | 1.59e-03 | 31 | 56 | 2 | EFO_0007760 | |
| Disease | phosphatidylcholine 38:5 measurement | 1.80e-03 | 33 | 56 | 2 | EFO_0010387 | |
| Disease | triacylglycerol 56:6 measurement | 3.04e-03 | 43 | 56 | 2 | EFO_0010433 | |
| Disease | cholesteryl ester 20:5 measurement | 3.18e-03 | 44 | 56 | 2 | EFO_0010349 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IKLNQPASLYCPHMV | 421 | Q6P461 | |
| RSCPGNYPMQHERKV | 106 | Q3SY05 | |
| CHIYCHRPKMEAVPE | 1701 | Q9UIF9 | |
| PAPQDHGRRLYKMLC | 316 | O96018 | |
| YGAQPVRPEMLKHCA | 346 | Q96NS5 | |
| PRCMFDHPDADKTLN | 1646 | Q9UPY3 | |
| KYCCSPKRVQMHPED | 931 | O75185 | |
| DHPNPAMAYANEVKR | 181 | Q8IUZ5 | |
| LDAYSHIPPQLMEKC | 411 | Q9H3S7 | |
| KYDPDPAPHMENLKC | 161 | Q96IY1 | |
| RLCMLYHPDKHRDPE | 36 | Q9NVH1 | |
| CKMCRPRAYIFSDPH | 176 | P0C5J1 | |
| TDPEKYPHMLSVKNC | 46 | Q9Y333 | |
| KKLPPGQQRFCHHMY | 36 | Q5DT21 | |
| PIHCPDYLRSAKMTE | 6 | Q53QV2 | |
| RYLPNQDCLEGKIMH | 146 | Q6ZUT3 | |
| KCHPDQEHMIYPLGC | 31 | Q8N1V2 | |
| AICNPLHYPDLMSRK | 116 | P0C7T2 | |
| NHSIPVYEMKFPDLC | 801 | Q9Y2G0 | |
| NCSPHMNVYLKEDIP | 286 | Q9Y6X5 | |
| YRAPCHMKETPATSA | 471 | A2RU67 | |
| AGDKDMYVCHQPLPT | 56 | P09848 | |
| SYPQNKRPVHMDRAC | 241 | Q8NFH4 | |
| MNHRAPANGRYKPTC | 11 | Q15546 | |
| ADLCYPFHGPAQMKV | 261 | P24387 | |
| YPPMCHLTVRINSAK | 296 | O95273 | |
| YPKPMVNHAEASRLN | 466 | Q16526 | |
| TPYLMLCQPHKRCGD | 31 | Q6UW32 | |
| VPDTRSKMCLQKHYP | 116 | Q7Z4T8 | |
| SKMCLQKHYPARLPT | 121 | Q7Z4T8 | |
| MPKLHEPYASSQCIA | 501 | O43303 | |
| AKPNCFRKDPDINMH | 221 | O60427 | |
| IYMAIEHSPNKCLPV | 121 | P32314 | |
| EADLRCMAVPPKYRH | 46 | Q9UK59 | |
| HCRYFPMLLNHPEKC | 116 | Q8NFL0 | |
| PMLLNHPEKCRGDVY | 121 | Q8NFL0 | |
| YFKISHEMLDQCPHP | 4001 | Q8IVF4 | |
| YCPMCNIKIHETQPL | 81 | Q9BSM1 | |
| VAICNPLHYDVVMKP | 161 | Q8NGR2 | |
| PYTIFHQALKNCEPM | 141 | Q9Y2R9 | |
| CQEMYKQPLVLPCTH | 36 | Q7Z4K8 | |
| YCQVIHRLPMPNLKD | 56 | Q13228 | |
| KQRHENCYFLHPPMP | 241 | Q9BQG2 | |
| DPAMALKHEERKCPY | 691 | O95785 | |
| HLRMCSAAPKLPYDL | 191 | Q9P0N9 | |
| PSCPTARMLDDLHKY | 476 | Q6NSI8 | |
| QCLDCRLMYPPHKFV | 246 | P12755 | |
| VHCDPNLDPKQYKMC | 836 | Q70JA7 | |
| PAANPTMIRAKCYHN | 1921 | A5YKK6 | |
| IAACNPYRKHSEEMI | 2521 | Q63HN8 | |
| DNISGMARCPYDPKH | 166 | Q9H3T3 | |
| MARCPYDPKHANVAL | 171 | Q9H3T3 | |
| RHMLTHAEDGPPYKC | 521 | P52737 | |
| CVLCKQPRHGAPMYR | 171 | Q8TB61 | |
| NFCPDHKAPMVLFLD | 2356 | Q15413 | |
| HKKYDPDLFRMALPC | 2551 | Q15413 | |
| PCIAAFADEHEMRKP | 296 | Q5T4T6 | |
| GYLMEVKPANACHPI | 131 | Q8WWF5 | |
| YDNPHMVPPDKCRCA | 81 | Q9Y6I9 | |
| PYACADPSRLKYHMR | 1486 | P52746 | |
| MKTPLKSANPVHACY | 491 | Q8NA31 | |
| CFPPTKIERHAMYCN | 511 | Q96RL1 | |
| RPDKCPCEVYHLMKN | 1136 | P29597 |